AC Immune SA (ACIU)
3.51
-0.12
(-3.31%)
USD |
NASDAQ |
Jan 16, 16:00
3.49
-0.02
(-0.57%)
Pre-Market: 09:06
AC Immune EPS Diluted (Quarterly): -0.1964 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 1.092 |
| CRISPR Therapeutics AG | -1.166 |
| Addex Therapeutics Ltd. | -2.099 |
| NewCelX Ltd. | -- |
| Molecular Partners AG | -0.3955 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.82M |
| Revenue (Quarterly) | 1.173M |
| Total Expenses (Quarterly) | 20.99M |
| Enterprise Value | 222.64M |
| Profit Margin (Quarterly) | -1.69K% |
| Earnings Yield | -24.00% |
| Normalized Earnings Yield | -23.88 |